On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
WednesdayOct 07, 2020 10:27 am

QualityStocksNewsBreaks – Exro Technologies Inc. (TSX.V: EXRO) (OTCQB: EXROF) Achieves ‘Amazing Breakthrough’ in Electric Bike Technology, Micro-Mobility Applications

Exro Technologies (TSX.V: EXRO) (OTCQB: EXROF), a leading technology company that has developed a new class of power electronics for electric motors and powertrains, today announced that third-party testing has proven its patented Coil Driver technology dramatically improves performance of electric bikes. According to the update, Vancouver-based Motorino Electric, a manufacturer and distributor of electric bikes and motorcycles, completed field testing of Exro's technology through 2020 against a standard electric bike. Testing found a more than 20% performance increase, and up to 50% in climbing conditions, of the Exro-enhanced electric bike. Exro will now start negotiations on a commercial product…

Continue Reading

WednesdayOct 07, 2020 10:22 am

QualityStocksNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Closing of Public Offering

Processa Pharmaceuticals (NASDAQ: PCSA) has closed its previously announced underwritten public offering of 4,800,000 shares of common stock, which were offered to the public for $4 per share. The clinical-stage biopharmaceutical company, which focuses on the development of drug products intended to provide treatment for and improve the survival and/or quality of life of patients who have a high unmet medical need condition or who have no alternative treatment, announced that the public offering resulted in gross proceeds of approximately $19.2 million. PCSA has filed a registration statement relating to the securities being sold with the Securities and Exchange Commission (“SEC”);…

Continue Reading

WednesdayOct 07, 2020 9:50 am

QualityStocksNewsBreaks – 180 Life Sciences Corp. Continues to Broaden Global IP Portfolio, Expand Internal Pipeline

KBL Merger Corp. (NASDAQ: KBLM) (KBL Merger Corp. Rights NASDAQ: KBLMR) (KBL Merger Corp. Warrant NASDAQ: KBLMW), a Special Purpose Acquisition Corporation (SPAC) that previously entered a definitive agreement to acquire 180 Life Sciences, a clinical-stage biotechnology company, on Tuesday announced continued expansion of 180 Life Sciences’ robust intellectual property (“IP”) portfolio. According to the update, 180 Life Sciences is an applicant and licensee of a broad and growing patent portfolio for three major drug platforms in the areas of inflammation, fibrosis and pain. The portfolio covers 14 patent families with 42 patents issued and 32 pending in several important…

Continue Reading

TuesdayOct 06, 2020 2:24 pm

The Movie Studio Inc. (MVES) Leveraging Social Media Branding and Influencer Engagement to Promote New App

MVES engaged services of Digital Talent Studio Inc., social media mogul Brian Breach of Sikey Corp. to promote The Movie Studio App The Movie Studio App leverages both advertiser-based and subscription models Social media models, influencers expected to promote app to hundreds of thousands of followers MVES’s two key verticals include open architecture for original content plus an over-the-top platform that pulls additional content through revenue sharing agreements In a bold move to boost the promotion of The Movie Studio App, The Movie Studio Inc. (OTC: MVES), a vertically integrated motion picture production and distribution company, has engaged Digital Talent…

Continue Reading

TuesdayOct 06, 2020 2:02 pm

Net Element Inc. (NASDAQ: NETE), Mullen Technologies Announce Facility Build-Out, Pre-Sales of Fully Electric EV

Mullen Technologies begins built-out of pilot facility, accepting orders for MX-05 SUV. Facility slated for April 2021 completion; first MX-05 SUVs rolling off production line by Q2 2022. In August, Net Element, Mullen Technologies announced execution of definitive agreement to merge. The announcement by Mullen Technologies Inc. that it has begun to build out its pilot manufacturing facility and take pre-orders for its M05 fully electric SUV bodes well for Net Element (NASDAQ: NETE). Earlier this year, Net Element, a global financial technology and value-added solutions group, and Mullen Technologies announced a merger agreement—so good news for Mullen means good…

Continue Reading

TuesdayOct 06, 2020 1:25 pm

QualityStocksNewsBreaks – The Alkaline Water Company Inc.’s (CSE: WTER) (NASDAQ: WTER) A88 Infused(TM) Grabbing Shelf Space in Trend Expected to Accelerate

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced that its A88 Infused(TM) brand is gaining ground in the fast-growing flavored water market. According to the update, A88 Infused flavored water is widely available through multiple channel partners across various trades. “Demand for our single-serve offerings are at an all-time high, and we are rapidly growing shelf space for our A88 Infused flavored waters,” WTER president and CEO Ricky Wright said in the press release. “Our channel partners are some of the leading players in the…

Continue Reading

TuesdayOct 06, 2020 12:51 pm

QualityStocksNewsBreaks – Predictive Oncology (NASDAQ: POAI) Shareholder Letter Provides Company Update, Status of Subsidiaries

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has released a shareholder letter providing a review of where POAI “stands as of today.” The letter noted that, despite a decline of stock price over the past few weeks, the company’s cash burn is stable and even trending down, and revenues are stable and trending upward. The letter notes that POAI has adequate cash for operation, as well as ability to utilize an equity line of credit of more than $10 million. The letter also provides an update on the…

Continue Reading

TuesdayOct 06, 2020 12:51 pm

Processa Pharmaceuticals Inc. (NASDAQ: PCSA) is “One to Watch”

Processa Pharmaceuticals aims to develop products where existing clinical evidence of efficacy already exists in the targeted unmet medical need condition with the drug itself or a drug with very similar pharmacology The Processa process focuses on the advancement of drugs that are ready for clinical development or have minimal pre-IND enabling studies to complete Processa’s current development pipeline features multiple clinical drug candidates, given the recent acquisitions of three additional development-focused licensing agreement since June 2020 In total, the company’s combined scientific, development and regulatory experience has resulted in more than 30 drug approvals by the U.S. Food and…

Continue Reading

TuesdayOct 06, 2020 12:08 pm

QualityStocksNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Engages IBN to Maximize Communication, Refine Messaging and Outreach

Kaival Brands (OTCQB: KAVL), a company focused on growing and incubating innovative and profitable products into mature, dominant brands, today announced it has selected the corporate communications expertise of the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. Kaival promotes innovative brand solutions and is the exclusive global distributor for Bidi(TM) Stick, an offering made from high-quality components and equipped with a long-lasting battery and class A nicotine. The company recently entered an agreement through which it will acquire exclusive rights to an international patent portfolio concerning full customization of certain isomeric properties of…

Continue Reading

TuesdayOct 06, 2020 12:02 pm

QualityStocksNewsBreaks – Grey Cloak Tech Inc. (GRCK) Launches New Product Designed to Boost Immune System

Grey Cloak Tech (OTC: GRCK), through its subsidiary BergaMet NA, has introduced Clinical IMMUNE(TM), a concentrated nutraceutical supplement formulated with naturally grown, heart-healthy Citrus Bergamot SuperFruit(TM), BetaVia(TM) Complete, and nine other powerful immune-boosting ingredients. The company is calling the product the No. 1 immune system defense for the body. Clinical IMMUNE contains natural ingredients, is GMO-free, and has been scientifically formulated to reduce upper respiratory symptoms, strengthen the body’s immune system, and maintain healthy blood sugar and blood pressure. The product also works to support a healthy cardiovascular system and address infectious conditions. Clinical IMMUNE offers two immune-building ingredients not found…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered